Sun Pharma secures marketing rights for stroke drug Tyvalzi from Pharmazz

Pallavi Madhiraju- September 15, 2023 0

Sun Pharmaceutical Industries Limited has entered into a license agreement with U.S.-based biopharmaceutical company Pharmazz Inc. for the commercialization of the first-in-class innovative drug, Tyvalzi ... Read More